Amerise Pharmaceuticals Private Limited, a active private limited company, was established on 09 October 2018 in Ahmadabad City, Gujarat, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U36900GJ2018PTC104672. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.10 Cr and a paid-up capital of ₹4.87 Cr.
Employing 3 professional, Its leadership includes Nirav Nalinkumar Vyas (Director), Jalpaben Niravkumar Vyas (Director). Past directors included Nileshbhai Yadav, Nirav Nalinkumar Vyas, Sanchit Kaushik Chaturvedi. Its latest AGM occurred on 20 July 2024, with the balance sheet filed on 31 March 2024. It is based at 709 Aaron Spectra Rajpath Rangoli Road, Behind Rajpath Club Bodakdev, Ahmadabad City, Gujarat, 380054.
U36900GJ2018PTC104672
104672
09 October 2018
₹6.10 Cr
₹4.87 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Amerise Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirav Nalinkumar Vyas | Director | 04 Sep 2021 | Current |
| Jalpaben Niravkumar Vyas | Director | 09 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 07 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 17 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amerise Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.19% increase. The company also saw a substantial fall in profitability, with a 18.32% decrease in profit. The company's net worth moved up by a moderate rise of 5.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Amerise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Amerise Pharmaceuticals has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Amerise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amerise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amerise Pharmaceuticals Private Limited last Annual general meeting of members was held on 20 Jul 2024 as per latest MCA records. was recorded as a recent event.
The activity Amerise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on Nirav Nalinkumar Vyas was appointed as a Director was appointed as a Director on 04 Sep 2021 & has been associated with this company since 4 years 2 months . was documented.
Jalpaben Niravkumar Vyas was appointed as a Director was appointed as a Director on 09 Oct 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.
The activity Amerise Pharmaceuticals Private Limited was registered on 09 Oct 2018 with Roc Ahmedabad & aged 7 years 1 month as per MCA records. was completed.
The CIN of Amerise Pharmaceuticals Private Limited is U36900GJ2018PTC104672.
Amerise Pharmaceuticals Private Limited is headquartered at 709 Aaron Spectra Rajpath Rangoli Road, Behind Rajpath Club Bodakdev, Ahmadabad City, Gujarat, 380054.
Amerise Pharmaceuticals Private Limited was incorporated on 09 October 2018.
The current directors of Amerise Pharmaceuticals Private Limited are
The primary industry of Amerise Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Amerise Pharmaceuticals Private Limited is unlisted.
The authorized capital of Amerise Pharmaceuticals Private Limited is ₹6.10 Cr, and the paid-up capital is ₹4.87 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX